Nutex Health (NUTX) Return on Capital Employed (2011 - 2026)

Nutex Health (NUTX) has 16 years of Return on Capital Employed data on file, last reported at 36.66% in Q1 2026.

• Quarterly Return on Capital Employed fell 429.0% year-over-year to 36.66% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 36.66% (down 429.0% YoY) and the FY2025 annual result came in at 43.82%, up 874.0% from the prior year.
• Return on Capital Employed advanced to 36.66% in Q1 2026 per NUTX's latest filing, from 35.17% in the prior quarter.
• The five-year high for Return on Capital Employed was 63.69% in Q1 2022, with the low at 116.91% in Q2 2023.
• Average Return on Capital Employed over 5 years is 6.09%, with a median of 2.68% recorded in 2024.
• Year-over-year, Return on Capital Employed sank 17863 bps in 2023 and surged 11100 bps in 2024.
• Nutex Health's Return on Capital Employed stood at 107.88% in 2022, then soared by 92 bps to 8.35% in 2023, then soared by 498 bps to 33.26% in 2024, then increased by 6 bps to 35.17% in 2025, then climbed by 4 bps to 36.66% in 2026.
• Business Quant data shows NUTX's Return on Capital Employed at 36.66% in Q1 2026, 35.17% in Q4 2025, and 50.04% in Q3 2025.